ResMed | Les Charges D'Exploitation



Operating Expenses Changement Date
Ansell USD 358.55M 386.85M 2024-06
AtriCure USD 138.8M 15.48M 2024-12
Baxter International USD 3.19B 644M 2024-12
Cochlear AUD 917M 73.4M 2024-06
Cooper Companies USD 782.7M 37.3M 2025-01
CSL USD 5.55B 108M 2024-06
Dexcom USD 924.6M 82.4M 2024-12
Edwards Lifesciences USD 1.07B 69.4M 2024-12
Fisher Paykel Healthcare NZD 733.1M 103.3M 2024-09
Globus Medical USD 597.02M 19.41M 2024-12
Haemonetics USD 289.51M 4.3M 2024-12
Hologic USD 792M 34M 2024-12
Idexx Laboratories USD 692.6M 20.95M 2024-12
Insulet USD 488.2M 32.4M 2024-12
Integra LifeSciences USD 407.42M 18.45M 2024-12
Intuitive Surgical USD 1.68B 882M 2024-12
Masimo USD 959.8M 485.3M 2024-12
Medtronic USD 6.65B 162M 2025-01
Philips EUR 4.85B 806M 2024-12
Ramsay Health Care AUD 8.35B 258.6M 2024-12
ResMed USD 864.85M 27.65M 2024-12
Sigma Healthcare AUD 1.87B 192.57M 2024-07
Sonic Healthcare AUD 4.23B 2.14B 2024-12
Steris USD 1.13B 9.69M 2024-12
Teleflex USD 905.79M 290.73M 2024-12
Thermo Fisher Scientific USD 9.38B 619M 2024-12



ResMed Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.